Treace Medical Concepts, Inc. (TMCI) Gross margin 2019–2025
Treace Medical Concepts, Inc. (TMCI) gross margin by fiscal year — reported gross profit divided by reported revenue.
79.8%FY2025 · since FY2019: 80.6% → 79.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 79.8% | -0.6 pp |
| FY2024 | 80.4% | -0.8 pp |
| FY2023 | 81.2% | -0.8 pp |
| FY2022 | 82.0% | -0.1 pp |
| FY2021 | 82.1% | +3.9 pp |
| FY2020 | 78.3% | -2.4 pp |
| FY2019 | 80.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice